HAE peer analysis
Haemonetics (HAE) against its competitors: price, today's move, 1-year return and market value side by side.
- HAE's peers: BEAM (Beam Therapeutics), BHC (Bausch Health), CON (Concentra), ITGR (Integer), LMAT (LeMaitre Vascular), PINC (PGIM Securitized Income), QDEL (QuidelOrtho), WRBY (Warby Parker).
HAE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BEAM Beam Therapeutics | $21.66 | 3.46% | 3.26% | $2.24B |
| BHC Bausch Health | $8.21 | -4.09% | 35.70% | $3.07B |
| CON Concentra | $41.84 | 0.94% | 117.58% | $5.29B |
| ITGR Integer | $126.97 | 0.21% | 82.72% | $4.32B |
| LMAT LeMaitre Vascular | $73.61 | -1.67% | -15.20% | $1.68B |
| PINC PGIM Securitized Income | $49.20 | -0.01% | – | – |
| QDEL QuidelOrtho | $8.35 | -6.39% | -60.22% | $572.92M |
| WRBY Warby Parker | $23.03 | -4.55% | 32.36% | $2.86B |
| XRAY Dentsply Sirona | $8.34 | -1.77% | -17.26% | $1.66B |
| HAE Haemonetics | $120.16 | -0.17% | 59.81% | $5.47B |